UBS Group’s Ambrx Biopharma, Inc. Common Stock AMAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,840
| Closed | -$54.7K | – | 8896 |
|
|
2023
Q4 | $54.7K | Sell |
3,840
-1,734
| -31% | -$24.7K | ﹤0.01% | 5287 |
|
|
2023
Q3 | $64.1K | Buy |
+5,574
| New | +$64.1K | ﹤0.01% | 5003 |
|
|
2023
Q2 | – | Sell |
-56,868
| Closed | -$507K | – | 8743 |
|
|
2023
Q1 | $507K | Buy |
56,868
+53,824
| +1,768% | +$480K | ﹤0.01% | 3696 |
|
|
2022
Q4 | $6.91K | Sell |
3,044
-4,923
| -62% | -$11.2K | ﹤0.01% | 7771 |
|
|
2022
Q3 | $9K | Buy |
7,967
+7,725
| +3,192% | +$8.73K | ﹤0.01% | 7523 |
|
|
2022
Q2 | $1K | Buy |
+242
| New | +$1K | ﹤0.01% | 9009 |
|